Page 3 - Atea Pharmaceutical News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Atea Pharmaceuticals, Inc (NASDAQ:AVIR) Q1 2023 Earnings Call Transcript

Operator: Good afternoon, ladies and gentlemen. Welcome to the Atea Pharmaceuticals’ First Quarter 2023 Financial Results and Business Update Conference Call.

Janet hammondJonae barnesArantxa horgaJohn vavrickaJohn millerJean pierre sommadossiAndrea corcoranMaxwell skorDeric josephMorgan stanleyHealth photoPublic health emergencyNational cancer institute on unsplashExchange commissionAtea pharmaceuticals incJp morgan

Q1 2023 EPS Estimates for Atea Pharmaceuticals, Inc Increased by SVB Leerink (NASDAQ:AVIR)

Atea Pharmaceuticals, Inc. (NASDAQ:AVIR – Get Rating) – Equities researchers at SVB Leerink raised their Q1 2023 earnings per share estimates for Atea Pharmaceuticals in a report issued on Wednesday, March 1st. SVB Leerink analyst R. Ruiz now anticipates that the company will post earnings of ($0.50) per share for the quarter, up from their […]

Morgan stanleyGeode capital managementAtea pharmaceuticals tradingBlackrock incVanguard group incNews ratings for atea pharmaceuticals dailyAtea pharmaceuticalsAtea pharmaceuticals incHermes incInstitutional trading of atea pharmaceuticalsGet ratingAtea pharmaceuticalStreet corpCapital managementAtea pharmaceuticals dailyNasdaq avir

Atea Pharmaceuticals, Inc (NASDAQ:AVIR) Q4 2022 Earnings Call Transcript

Operator: Good afternoon, ladies and gentlemen. Welcome to the Atea Pharmaceuticals Fourth Quarter and Full Year 2022 Financial Results and Business Update Conference Call.

United statesJean pierre sommadossiJohn vavrickaArantxa horgaJanet hammondTim lugoMatthew harrisonAndrea corcoranJean sommadossiWilliam blairJonae barnesRoanna ruizMorgan stanleyCorporate communications at atea pharmaceuticalsGeneration battery technology companiesExchange commission

Atea Pharmaceuticals, Inc (AVIR) Q4 2021 Earnings Call Transcript

AVIR earnings call for the period ending December 31, 2021.

United statesJean pierre sommadossiJohn vavrickaAndrea corcoranJanet hammondJonae barnesExchange commissionAtea pharmaceuticalsNature communicationsCorporate communicationsAtea pharmaceuticals incVice presidentInvestor relationsAtea pharmaceuticalPierre sommadossiExecutive officer

Verona Pharma (NASDAQ:VRNA) & Atea Pharmaceuticals (NASDAQ:AVIR) Head-To-Head Analysis

Verona Pharma (NASDAQ:VRNA) & Atea Pharmaceuticals (NASDAQ:AVIR) Head-To-Head Analysis
etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.

United kingdomCity ofVerona pharmaMichael ja walkerVerona pharma plcAtea pharmaceuticalsGiven verona pharmaAtea pharmaceuticalPharma plc